AN2 Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Chanda Sanjay | Chief Development Officer | Award / Grant | 27,500 | — | — | 28,235 | Mar 15, 2024 |
| Eckburg Paul | Chief Medical Officer | Award / Grant | 30,000 | — | — | 51,416 | Mar 15, 2024 |
| Easom Eric | Chief Executive Officer | Award / Grant | 99,000 | — | — | 101,130 | Mar 15, 2024 |
| Zakrzewski Joseph S | — | Sale | 100,000 | $19.11 | $1,911,000 | 405,880 | Jan 18, 2024 |
| Aziz Kabeer | — | Sale | 15,907 | $19.65 | $312,573 | 377,542 | Jan 16, 2024 |
| Adjuvant Capital Management, LLC | — | Sale | 84,093 | $19.65 | $1,652,427 | 1,995,958 | Jan 16, 2024 |
| Readnour Robin Shane | — | Sale | 719 | $21.91 | $15,753 | 485,073 | Jan 12, 2024 |
| Readnour Robin Shane | — | Sale | 1,800 | $21.92 | $39,456 | 485,792 | Jan 10, 2024 |
| Krause Kevin Michael | Chief Strategy Officer | Option Exercise | 5,000 | $6.60 | $33,000 | 9,331 | Jan 9, 2024 |
| Krause Kevin Michael | Chief Strategy Officer | Sale | 2,583 | $20.12 | $51,970 | 1,914 | Jan 2, 2024 |
| Easom Eric | Chief Executive Officer | Sale | 2,777 | $20.09 | $55,790 | 2,130 | Jan 2, 2024 |
| Adjuvant Capital Management, LLC | — | Sale | 1,522 | $16.15 | $24,580 | 2,080,051 | Nov 14, 2023 |
| Aziz Kabeer | — | Sale | 1,522 | $16.15 | $24,580 | 2,080,051 | Nov 14, 2023 |
| Aziz Kabeer | — | Sale | 4,770 | $16.07 | $76,654 | 2,081,573 | Oct 2, 2023 |
| Adjuvant Global Health Technology Fund, L.P. | — | Sale | 83,337 | $16.28 | $1,356,726 | 2,086,343 | Oct 2, 2023 |
| Adjuvant Global Health Technology Fund DE, L.P. | — | Sale | 1,356 | $16.11 | $21,845 | 410,403 | Sep 27, 2023 |
| Aziz Kabeer | — | Sale | 707 | $16.07 | $11,361 | 2,176,840 | Sep 27, 2023 |
| Aziz Kabeer | — | Sale | 336 | $16.00 | $5,376 | 2,177,547 | Sep 13, 2023 |
| Adjuvant Global Health Technology Fund, L.P. | — | Sale | 64 | $16.00 | $1,024 | 411,893 | Sep 13, 2023 |
| Aziz Kabeer | — | Sale | 598 | $16.02 | $9,580 | 412,494 | Sep 7, 2023 |
| Adjuvant Global Health Technology Fund DE, L.P. | — | Sale | 2,841 | $16.05 | $45,598 | 2,177,883 | Sep 6, 2023 |
| Adjuvant Capital GP, L.P. | — | Sale | 64 | $16.00 | $1,024 | 413,092 | Aug 23, 2023 |
| Aziz Kabeer | — | Sale | 64 | $16.00 | $1,024 | 413,092 | Aug 23, 2023 |
| RA Capital Nexus Fund II, L.P. | — | Purchase | 1,777,778 | $9.00 | $16,000,002 | 5,135,683 | Aug 18, 2023 |
| Easom Eric | Chief Executive Officer | Purchase | 10,000 | $5.38 | $53,800 | 1,015,766 | May 15, 2023 |
| Easom Eric | Chief Executive Officer | Sale | 23 | $15.04 | $346 | 4,907 | Nov 10, 2022 |
| Easom Eric | Chief Executive Officer | Sale | 10,111 | $15.61 | $157,833 | 4,907 | Nov 8, 2022 |
| Easom Eric | Chief Executive Officer | Sale | 10,167 | $15.90 | $161,655 | 6,943 | Nov 3, 2022 |
| Easom Eric | Chief Executive Officer | Sale | 1,544 | $15.07 | $23,268 | 4,907 | Oct 31, 2022 |
| Easom Eric | Chief Executive Officer | Sale | 924 | $15.36 | $14,193 | 6,590 | Oct 28, 2022 |
| Easom Eric | Chief Executive Officer | Sale | 4,272 | $15.69 | $67,028 | 7,119 | Oct 24, 2022 |
| Easom Eric | Chief Executive Officer | Sale | 11,601 | $16.29 | $188,980 | 7,257 | Oct 20, 2022 |
| Shah Rajeev M. | — | Purchase | 1,809 | $7.48 | $13,531 | 3,773,417 | Aug 4, 2022 |
| RA Capital Nexus Fund II, L.P. | — | Purchase | 14,938 | $7.71 | $115,172 | 3,763,327 | Jul 27, 2022 |
| Shah Rajeev M. | — | Purchase | 302 | $7.99 | $2,413 | 3,748,389 | Jun 21, 2022 |
| RA Capital Nexus Fund II, L.P. | — | Purchase | 20,000 | $7.90 | $158,000 | 3,686,663 | Jun 14, 2022 |
| Adjuvant Global Health Technology Fund, L.P. | — | Other | 26,511 | $15.00 | $397,665 | 413,156 | Jun 6, 2022 |
| Aziz Kabeer | — | Other | 26,511 | $15.00 | $397,665 | 2,184,224 | Jun 6, 2022 |
| Adjuvant Global Health Technology Fund DE, L.P. | — | C | 392,433 | — | — | 2,044,069 | Mar 29, 2022 |
| Zakrzewski Joseph S | — | C | 98,199 | — | — | 98,199 | Mar 29, 2022 |
| Readnour Robin Shane | — | Purchase | 82,618 | $15.00 | $1,239,270 | 487,592 | Mar 29, 2022 |
| Adjuvant Global Health Technology Fund, L.P. | — | Purchase | 166,666 | $15.00 | $2,499,990 | 2,210,735 | Mar 29, 2022 |
| Easom Eric | Chief Executive Officer | C | 4,907 | — | — | 4,907 | Mar 29, 2022 |
| Aziz Kabeer | — | C | 74,230 | — | — | 386,645 | Mar 29, 2022 |
| Kolchinsky Peter | — | Purchase | 1,551,053 | $15.00 | $23,265,795 | 3,251,051 | Mar 29, 2022 |